Get the Stockscreener App
46.70
5.16%
-2.54
ARK Genomic Revolution ETF Stock (ARKG) Forecast
The ARK Genomic Revolution ETF (ARKG) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $42.87, representing a -8.19% decrease from the current price of $46.70. The highest analyst price target is $51.51, and the lowest is $34.24.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ARKG Price Target
Average 25.95
(-44.44% Downside)
Is ARK Genomic Revolution ETF (ARKG) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 40.71 | Neutral |
| STOCH(9,6) | 12.64 | Buy |
| STOCHRSI(14) | 10.47 | Buy |
| MACD(12,26) | -0.1291 | Sell |
| ADX(14) | 25.07 | Buy |
| William %R | -97.63 | Buy |
| CCI(14) | -86.94 | Neutral |
Buy: 4
Sell: 1
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
50.15
Sell
|
49.58
Sell
|
| MA20 |
51.63
Sell
|
50.15
Sell
|
| MA50 |
48.79
Sell
|
48.18
Sell
|
| MA100 |
43.45
Buy
|
44.13
Buy
|
| MA200 |
36.38
Buy
|
38.90
Buy
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, ARKG could be considered a Potential Buy, with 17 technical analysis indicators signaling 8 Buy signals, 7 signaling Sell signals and 2 Neutral signals. This might be a good time to open fresh positions on ARKG, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 40.71 indicates that ARKG is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 12.64 indicates that ARKG is oversold. This indicates that ARKG price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 10.47 indicates that ARKG is oversold. This suggests that ARKG price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 25.07 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -86.94 indicates that ARKG is still oversold but not to an extreme extent.
Long-term ARKG price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about ARK Genomic Revolution ETF financial reports and earnings history, ARK Genomic Revolution ETF (ARKG) stock could reach $5.1035 by 2030, $39.21 by 2040 and $102.03 by 2050. See the projected annual prices until 2050 of the ARK Genomic Revolution ETF stock below:
- ARK Genomic Revolution ETF (ARKG) is expected to reach an average price of $16.06 in 2035, with a high prediction of $17.21 and a low estimate of $17.76. This indicates an $-65.61% rise from the last recorded price of $46.70.
- ARK Genomic Revolution ETF (ARKG) stock is projected to chart a bullish course in 2040, with an average price target of $36.27, representing an $-22.32% surge from its current level. The forecast ranges from a conservative $37.50 to a sky-high $39.21.
- Our analysts predict ARK Genomic Revolution ETF (ARKG) to jump 55.39% by 2045, soaring from $71.37 to an average price of $72.57, potentially reaching $71.02. While $71.37 is the low estimate, the potential upside is significant.
- ARK Genomic Revolution ETF (ARKG) stock is expected to climb by 2050, reaching an average of $100.88, a $116.01% jump from its current level. However, a wide range of estimates exists, with high and low targets of $102.03 and $101.50, respectively, highlighting the market's uncertainty.
ARK Genomic Revolution ETF Stock (ARKG) Year by Year Forecast
ARK Genomic Revolution ETF Stock (ARKG) Price Forecast for 2026
The predicted value for ARK Genomic Revolution ETF (ARKG) in 2026 is set at an average of $41.72. Estimates vary from a peak of $58.83 to a trough of $24.60, indicating an -10.67% surge from the present price of $46.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $35.43 | $34.24 | $51.51 | -24.14% |
| December, 2026 | $36.60 | $28.21 | $38.05 | -21.63% |
ARK Genomic Revolution ETF Stock (ARKG) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for ARK Genomic Revolution ETF (ARKG) is $18.43, with a high forecast of $36.47 and a low forecast of $0.3796. This indicates an -60.54% decrease from the last price of $46.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $18.95 | $18.92 | $36.47 | -59.43% |
| February, 2027 | $21.03 | $15.21 | $24.96 | -54.98% |
| March, 2027 | $13.36 | $13.19 | $22.43 | -71.40% |
| April, 2027 | $20.84 | $10.64 | $21.80 | -55.38% |
| May, 2027 | $5.7091 | $4.9101 | $22.10 | -87.78% |
| June, 2027 | $5.3927 | $0.495 | $6.7827 | -88.45% |
| July, 2027 | $7.8963 | $0.3796 | $7.9163 | -83.09% |
| August, 2027 | $10.26 | $4.1822 | $12.77 | -78.04% |
| September, 2027 | $9.9995 | $9.2777 | $17.44 | -78.59% |
| October, 2027 | $11.48 | $7.5631 | $12.69 | -75.41% |
| November, 2027 | $4.4427 | $4.1427 | $12.39 | -90.49% |
| December, 2027 | $6.5763 | $3.7186 | $9.3663 | -85.92% |
ARK Genomic Revolution ETF Stock (ARKG) Price Forecast for 2028
In 2028, ARK Genomic Revolution ETF (ARKG) is projected to reach an average price of $7.939, with a high projection of $14.51 and a low estimate of $1.3695. This indicates an -83.00% fall from the last price of $46.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $7.2258 | $4.517 | $11.07 | -84.53% |
| February, 2028 | $2.6195 | $1.3695 | $7.6177 | -94.39% |
| March, 2028 | $8.5931 | $1.7854 | $8.8572 | -81.60% |
| April, 2028 | $7.1467 | $6.0967 | $11.76 | -84.70% |
| May, 2028 | $3.3763 | $1.5854 | $6.5427 | -92.77% |
| June, 2028 | $5.3099 | $2.6822 | $6.1299 | -88.63% |
| July, 2028 | $6.0295 | $3.2317 | $6.4936 | -87.09% |
| August, 2028 | $8.6431 | $6.0654 | $10.23 | -81.49% |
| September, 2028 | $8.6167 | $7.6508 | $10.96 | -81.55% |
| October, 2028 | $9.6363 | $8.5326 | $14.51 | -79.37% |
| November, 2028 | $8.0399 | $5.5681 | $9.6822 | -82.78% |
| December, 2028 | $3.8435 | $3.8085 | $8.9058 | -91.77% |
ARK Genomic Revolution ETF Stock (ARKG) Price Forecast for 2029
The 2029 price forecast for ARK Genomic Revolution ETF Stock (ARKG) is $5.4812 on average, with a high prediction of $10.88 and a low estimate of $0.0844. This represents an -88.26% decrease from the previous price of $46.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.6469 | $0.4428 | $4.4744 | -96.47% |
| February, 2029 | $3.8267 | $0.5292 | $3.9217 | -91.81% |
| March, 2029 | $5.0003 | $3.4026 | $5.8699 | -89.29% |
| April, 2029 | $7.2599 | $4.1162 | $10.88 | -84.45% |
| May, 2029 | $5.8835 | $4.8145 | $7.3676 | -87.40% |
| June, 2029 | $8.3771 | $4.7944 | $10.02 | -82.06% |
| July, 2029 | $5.8067 | $4.8408 | $9.2181 | -87.57% |
| August, 2029 | $0.3703 | $0.0844 | $5.9926 | -99.21% |
| September, 2029 | $3.864 | $0.4221 | $5.114 | -91.73% |
| October, 2029 | $1.8835 | $1.5135 | $4.2376 | -95.97% |
| November, 2029 | $3.0371 | $0.2553 | $5.3371 | -93.50% |
| December, 2029 | $3.8367 | $0.1308 | $5.6539 | -91.78% |
ARK Genomic Revolution ETF Stock (ARKG) Price Forecast for 2030
ARK Genomic Revolution ETF Stock (ARKG) is expected to reach an average price of $5.0433 in 2030, with a high forecast of $10.07 and a low forecast of $0.0127. This signifies an -89.20% decrease from the last price of $46.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $4.1003 | $1.8544 | $5.1035 | -91.22% |
| February, 2030 | $2.9839 | $2.4239 | $5.4912 | -93.61% |
| March, 2030 | $1.4076 | $1.4017 | $3.4357 | -96.99% |
| April, 2030 | $4.4271 | $0.6812 | $6.1103 | -90.52% |
| May, 2030 | $3.0207 | $1.0248 | $5.8789 | -93.53% |
| June, 2030 | $2.8444 | $2.0266 | $5.7985 | -93.91% |
| July, 2030 | $5.8539 | $3.4803 | $10.07 | -87.46% |
| August, 2030 | $2.3775 | $0.5816 | $6.2098 | -94.91% |
| September, 2030 | $0.0929 | $0.4379 | $3.2785 | -99.80% |
| October, 2030 | $0.5107 | $0.3693 | $2.3948 | -98.91% |
| November, 2030 | $2.8044 | $0.0127 | $3.0444 | -93.99% |
| December, 2030 | $5.0939 | $2.4823 | $5.2339 | -89.09% |
0.48%
0.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):